Table of Contents Author Guidelines Submit a Manuscript
Advances in Virology
Volume 2010, Article ID 407476, 5 pages
http://dx.doi.org/10.1155/2010/407476
Research Article

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children

1Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutricion, 14000 Ciudad de México, DF, Mexico
2Westat, Rockville, MD 20850-3129, USA
3Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, 6100 Executive Boulevard, Room 4B11, Bethesda, MD 20892-7510, USA

Received 28 October 2010; Accepted 24 December 2010

Academic Editor: George K. Lewis

Copyright © 2010 Luis E. Soto-Ramirez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Cane, I. Chrystie, D. Dunn et al., “Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study,” BMJ, vol. 331, no. 7529, p. 1368, 2005. View at Google Scholar · View at Scopus
  2. H. S. Weinstock, I. Zaidi, W. Heneine et al., “The epidemiology of antiretroviral drag resistance among drug-naive HIV-1-infected persons in 10 US cities,” Journal of Infectious Diseases, vol. 189, no. 12, pp. 2174–2180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. J. Wensing, D. A. van de Vijver, G. Angarano et al., “Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management,” Journal of Infectious Diseases, vol. 192, no. 6, pp. 958–966, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Panel on Antiretroviral Guidelines for Adult and Adolescents, “Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,” Department of Health and Human Services, December 2009, http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
  5. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, “Guidelines for the use of antiretroviral agents in pediatric HIV infection,” February 2009, http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf.
  6. M. Karchava, W. Pulver, L. Smith et al., “Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York state,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 5, pp. 614–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Persaud, P. Palumbo, C. Ziemniak et al., “Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States,” Journal of Infectious Diseases, vol. 195, no. 10, pp. 1402–1410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Chakraborty, C. J. Smith, D. Dunn et al., “HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004,” Pediatric Infectious Disease Journal, vol. 27, no. 5, pp. 457–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Pedroso, A. T. L. Queiroz, L. C. Alcântara et al., “High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil,” Journal of Acquired Immune Deficiency Syndromes, vol. 45, no. 2, pp. 251–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Vignoles, G. Barboni, M. R. Agosti et al., “High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children,” Antiviral Therapy, vol. 12, no. 7, pp. 1133–1137, 2007. View at Google Scholar · View at Scopus
  11. R. Hazra, S. K. Stoszek, L. F. Hance et al., “Cohort profile: NICHD international site development initiative (nisdi): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and caribbean countries,” International Journal of Epidemiology, vol. 38, no. 5, pp. 1207–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. E. Bennett, R. J. Camacho, D. Otelea et al., “Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update,” PLoS ONE, vol. 4, no. 3, Article ID e4724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. J. Almeida, E. N. Berezin, R. Rodrigues et al., “Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children,” Jornal de Pediatria, vol. 85, no. 2, pp. 104–109, 2009. View at Publisher · View at Google Scholar · View at Scopus